Home > Drug Search >
  • company_query: Biofrontera
  •   > 
Drug Filter
Category:
chemistry (29) biology (4)
Status:
NDA Filing (2) Phase Ⅲ (3) Phase Ⅱ (16) Phase Ⅰ (9) IND Filing (3)
Clinical Stage:
Pending (2) Active (24) Discontinued (4)
Bio-Type:
Gene therapy (2) CAR T cell therapy (1) Fusion protein (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute pyelonephritis (AP) (1) Alzheimer's disease (AD) (2) Anemia (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (1) Cancer related pain (1) Complicated urinary tract infection (1) Female sexual dysfunction (1) Generalised anxiety disorder (GAD) (2) HCV infection (2) Hypercholesterolemia (1) Idiopathic pulmonary fibrosis (IPF) (1) Major depressive disorder (MDD) (2) Migraine (1) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (2) Percutaneous coronary intervention (PCI) (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Social withdrawal (1) Solid tumours (4) Type 2 diabetes (1) Urticaria (1) Head and neck cancer (1) Nosocomial Pneumonia (NP) (1) Hyperlipoproteinaemia type IIa (1) Systemic bacterial infections (1) Autoimmune diseases (1) Glioblastoma (1) Esophagus cancer (1) Graft versus host disease (1) Mesothelioma (1) Urinary tract stones (1) Cutaneous neoplasms (1) Wilson’s disease (1) Musculoskeletal pain (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top